Operational, not clinical. This article covers the operational mechanics of routing a prescription through Crystal Clear. The clinical decision-making (who, what, dose, frequency) is yours.

Before you write

Three things to confirm:

1. Patient state of residence is in the pharmacy's shipping footprint. The availability map on the home page reflects active states.
2. You are licensed to prescribe in the patient's state. The intersection of your licensure and the pharmacy's licensure is the deliverable footprint.
3. The compound and configuration are on the active formulary, or you have flagged a custom request. If custom, write the prescription clearly and expect a clarifying call from the pharmacy if anything is ambiguous.

What goes on the prescription

The standard required elements, plus a few specifics for compounded medications:

• Patient identification. Full name, date of birth, complete shipping address (including the unit number, if applicable).
• Medication and configuration. The compound, the concentration (mg/mL or units/mL), the total volume per vial, and any vehicle / diluent specifics.
• Dose, route, frequency, and duration. The SIG. Be explicit about route (subcutaneous, intramuscular, intranasal, oral, etc.) so the pharmacy can label appropriately.
• Quantity to dispense. Number of vials, single- or multi-dose. For multi-dose vials, indicate the expected number of doses per vial so the labeling matches.
• Refills. The number of refills authorized.
• Prescriber identification. NPI, DEA if applicable, signature, and date.

Patient-specific is not optional. Section 503A requires that every prescription identify a specific patient. Generic or office-stock prescriptions cannot be filled. If the pharmacy receives a script that does not identify a patient, they will reach back rather than fill it.

Where to send it

Approved network providers receive the prescription routing details (e-Rx system identifier, fax number for hand-written scripts, secure-portal upload for atypical workflows) during the partnership conversation. The current path supports both e-prescribing and traditional fax-and-confirm for prescribers whose EMR does not connect cleanly to compounding pharmacies.

What the patient sees

Step 1: Pharmacy receipt and verification

The pharmacy confirms receipt of the prescription with the patient (typically by phone or email). The patient confirms their shipping address and any allergy or sensitivity flags.

Step 2: Compounding

The compound is prepared to your prescription. Same-day to 72-hour turnaround depending on complexity.

Step 3: Cold-chain shipment

Insulated packaging with gel coolant, ground or expedited based on transit time. Tracking comes from the pharmacy directly.

Step 4: Patient receives and stores

Standard instructions on the label cover storage. Refrigeration handling and travel guidance are covered in the patient-facing resources.

Step 5: First dose

The patient follows your specific instructions. Patient-facing technique resources supplement your prescription, they do not replace it.

Common pitfalls

• Vague SIG. "As directed" on a compounded medication often triggers a callback. Specific instructions land on the patient label and reduce confusion at first dose.
• Concentration assumptions. If you intend a specific concentration that is not the catalog default, write it explicitly. The pharmacy will not assume.
• Multi-dose vials without dose-count guidance. The labeling and patient education are clearer when the expected dose count per vial is on the prescription.
• Refrigeration mismatches. Some patients travel routinely and benefit from explicit guidance about storage during transit. A short note on the prescription helps the pharmacy include the right secondary instructions.
• State-line edge cases. Patients who recently moved or split time between states benefit from the prescription reflecting the actual delivery state, which may differ from the patient's historical record.